These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25728498)

  • 61. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers.
    Tang B; Kruger WD; Chen G; Shen F; Lin WY; Mboup S; London WT; Evans AA
    J Med Virol; 2004 Jan; 72(1):35-40. PubMed ID: 14635008
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
    Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
    World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
    Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
    Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
    Evans AA; O'Connell AP; Pugh JC; Mason WS; Shen FM; Chen GC; Lin WY; Dia A; M'Boup S; Dramé B; London WT
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):559-65. PubMed ID: 9681522
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.
    Yeung P; Wong DK; Lai CL; Fung J; Seto WK; Yuen MF
    J Infect Dis; 2011 Mar; 203(5):646-54. PubMed ID: 21227916
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pre-S deletion and complex mutations of hepatitis B virus related to young age hepatocellular carcinoma in Qidong, China.
    Qu L; Kuai X; Liu T; Chen T; Ni Z; Shen X
    PLoS One; 2013; 8(3):e59583. PubMed ID: 23555717
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
    Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
    Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection.
    Sezaki H; Kobayashi M; Hosaka T; Someya T; Akuta N; Suzuki F; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Sato J; Kumada H
    J Gastroenterol; 2004 Jun; 39(6):550-6. PubMed ID: 15235872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association between polymorphisms of the
    He XT; Xu HQ; Wang XM; He XS; Niu JQ; Gao PJ
    World J Gastroenterol; 2017 Jan; 23(2):232-241. PubMed ID: 28127197
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan.
    Chen CL; Yang WS; Yang HI; Chen CF; You SL; Wang LY; Lu SN; Liu CJ; Kao JH; Chen PJ; Chen DS; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1659-71. PubMed ID: 24895413
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen.
    Cheuk-Fung Yip T; Wai-Sun Wong V; Lik-Yuen Chan H; Tse YK; Pik-Shan Kong A; Long-Yan Lam K; Chung-Yan Lui G; Lai-Hung Wong G
    Clin Gastroenterol Hepatol; 2018 May; 16(5):765-773.e2. PubMed ID: 29246694
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China.
    Wang Y; Shu M; Chen J; Shen F; Ren H; Yu Y
    Front Public Health; 2023; 11():1302183. PubMed ID: 38179572
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
    Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
    Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV.
    Chen HL; Lin LH; Hu FC; Lee JT; Lin WT; Yang YJ; Huang FC; Wu SF; Chen SC; Wen WH; Chu CH; Ni YH; Hsu HY; Tsai PL; Chiang CL; Shyu MK; Lee PI; Chang FY; Chang MH
    Gastroenterology; 2012 Apr; 142(4):773-781.e2. PubMed ID: 22198276
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.
    Hernandez BY; Zhu X; Kwee S; Chan OT; Tsai N; Okimoto G; Horio D; McGlynn KA; Altekruse S; Wong LL
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2016-23. PubMed ID: 23983238
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China.
    Ding X; Mizokami M; Yao G; Xu B; Orito E; Ueda R; Nakanishi M
    Intervirology; 2001; 44(1):43-7. PubMed ID: 11223719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.
    Wong GL; Hui VW; Yip TC; Liang LY; Zhang X; Tse YK; Lai JC; Chan HL; Wong VW
    Aliment Pharmacol Ther; 2022 Sep; 56(5):869-877. PubMed ID: 35864571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.